Indivior Pharmaceuticals, Inc. INDV
Super Investor & Insider
1
Fondi che lo detengono
#767
Rank consenso
1.4%
% dei portafogli
$212.9M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Howard Marks · Oaktree Capital Management | 3.6% | Buy | 6,984,102 | $212.9M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on treating substance use disorders and related mental health conditions. The company concentrates on evidence-based therapies for opioid use disorder, including long-acting injectable and sublingual formulations designed to support adherence …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees827
TickerINDV
Statistics
Market Cap$4.63B
Revenue (TTM)$1.24B
Net Income$210.0M
Net Margin16.9%
EPS$1.64
P/E19.53
P/S3.49
P/B-33.22
EV/EBITDA10.48
ROE-212.1%
Dividend Yield—
Price$37.94
Data: Twelve Data · Revenue = mcap / P/S